March 3, 2026Open Access

First-trimester adipocytokine levels as predictive biomarkers for preeclampsia: a prospective case-control study

Key Points

First-trimester adipocytokines can predict preeclampsia risk with significant accuracy.
Resistin shows superior diagnostic performance among assessed adipocytokines.
The combination of multiple biomarkers increases prediction accuracy beyond individual testing.
These findings highlight the need for validation in varied populations to ensure applicability.

Abstract

First-trimester adipocytokines demonstrate significant predictive capability for the development of preeclampsia, with resistin showing superior diagnostic performance. The combination of multiple biomarkers enhances predictive accuracy beyond individual markers. These findings support the potential integration of adipocytokine assessment into early pregnancy screening protocols, pending validation in diverse populations.

First-trimester adipocytokine levels as predictive biomarkers for preeclampsia: a prospective case-control study

Key Points

Abstract

Cite This Study